A second set of analyses examined people who already had a substance use disorder to see whether they later had substance-related emergency department visits, hospital admissions, deaths, overdoses, or suicidal ideation or attempts
The dual GIP/GLP-1 receptor agonist has shown superior efficacy in weight reduction and metabolic improvement, and its European rollout marks a significant milestone in expanding the availability of next-generation obesity drugs beyond the U.S
When you are on GLP-1 drugs, what you eat can significantly impact your health and the effectiveness of the medication
12,19-21 It is also possible that migraine-associated and nonmigraine CVS are two entirely different disorders with different pathophysiologies
WINREVAIR is given once every three weeks as a single injection under the skin and can be administered by patients or caregivers under the guidance, training, and follow-up of a healthcare provider